Location History:
- Puschino Moskovskaya obl., RU (2022)
- Puschino, RU (2021 - 2024)
Company Filing History:
Years Active: 2021-2025
Title: Andrei Borisovich Ulitin: Innovator in Biotechnology
Introduction
Andrei Borisovich Ulitin is a prominent inventor based in Puschino, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 6 patents to his name, Ulitin's work is paving the way for advancements in medical treatments.
Latest Patents
Ulitin's latest patents include a monoclonal antibody that binds specifically to GITR. This invention relates to biotechnology and focuses on antibodies or antigen-binding fragments, as well as their applications. The invention also encompasses a nucleic acid encoding the antibody, an expression vector, and methods for preparing the antibody, which can be used in treating diseases associated with GITR. Another notable patent involves an antibody or antigen-binding fragment capable of binding to a human receptor of interleukin-6. This invention addresses the need for alternative antibodies that can specifically bind to this receptor, offering potential therapeutic applications for diseases mediated by interleukin-6.
Career Highlights
Throughout his career, Ulitin has demonstrated a commitment to innovation in the medical field. His research has led to the development of novel therapeutic agents that have the potential to improve patient outcomes. His expertise in biotechnology has positioned him as a key figure in the advancement of antibody-based treatments.
Collaborations
Ulitin has collaborated with notable colleagues, including Valery Vladimirovich Solovyev and Dmitry Valentinovich Morozov. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in biotechnology.
Conclusion
Andrei Borisovich Ulitin's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the medical field, offering promising avenues for treatment and diagnosis.